RecruitingNot ApplicableNCT06446817
Bicentric Clinical Investigation to Assess Safety and Performance of LuxHighAdd IOL
Multicentric Clinical Investigation to Determine Safety and Efficacy of a Hydrophobic Acrylic Multifocal Intraocular Lens
Sponsor
Cutting Edge SAS
Enrollment
57 participants
Start Date
Dec 19, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.
Eligibility
Min Age: 50 Years
Inclusion Criteria9
- Subject aged 50 or over on the day of inclusion, presenting a bilateral cataract, qualified for bilateral implantation
- No ocular comorbidity possibly affecting the study results
- Fit within the available IOL diopter range
- Have had no previous refractive surgery
- Regular corneal astigmatism ≤1.0 dioptres
- Clear intraocular media other than cataract
- Availability, willingness and sufficient cognitive awareness to comply with examination procedures
- Ability to attend all study follow-ups
- Signed informed consent.
Exclusion Criteria14
- Ocular surface disease potentially affecting study results
- Pre-existing ocular pathology or history of pathology potentially affecting the study results
- Acute or chronic disease or illness that would increase risk or confound study results
- Subjects who may be reasonably expected to require a secondary surgical intervention at any time during the investigation (other than YAG capsulotomy)
- Axial lengths and keratometry such as the IOL spherical power is not in the range of 16 to 26 D
- Instability of keratometry or biometry measurements
- Traumatic cataract
- Amblyopia
- History of ocular trauma or any prior ocular surgery including refractive procedures
- Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens
- Pupil abnormalities
- Systemic or ocular medication that could modify pupil dynamics
- Expected complicated surgery or complicated surgery
- Concurrent participation in another drug or device investigation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICELuxHighAdd IOL
Bilateral implantation in the capsular bag to replace the cataractous human crystalline lens.
DEVICELuxGood IOL
Bilateral implantation in the capsular bag to replace the cataractous human crystalline lens.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06446817
Related Trials
Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice
NCT070150342 locations
Dexmedetomidine and Propofol for Sedation in Cataract Surgery.
NCT075561331 location
Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NCT071264703 locations
Functional IOL Implantation in Patients With Epiretinal Membrane
NCT067197392 locations
Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery
NCT070802291 location